Home
About Us
Company Profile
Culture
Our Team
Video Display
Products
HEALMUS
SYLVIRENE
DERMFREE
BOTASUN
FLOBOW
PUVIDA
FLOCEAN
REINREUDE
FOLUPIA
SERYNTH
SKAPEMED
Beilloso
本間製薬
OTHER
Strength
Equipments
Certificates
Service
Service Process
Corperation Case
Blogs
Company News
Industry News
Contact Us
Stay updated with our latest developments and insights.
Zhongletang Pharmaceutical has launched a next-generation, upgraded anti-scar gel, whose formulation is registered with the U.S. Food and Drug Administration (FDA).
Recently, Jiangxi Zhongletang Pharmaceutical Co., Ltd. officially launched an upgraded version of its anti-scar gel. The formulation has been refined by the company’s in-house R&D team, incorporating milder, safer natural active ingredients. It demonstrates significant improvements in post-surgical scar management, burn healing, and other skin concerns. The product is registered with the U.S. Food and Drug Administration, and the first batch is now available on the U.S. market, offering global consumers a safer, more effective solution for skin repair.
11
2025
/
06
Zhongletang Pharmaceutical has helped a North American pharmacy chain launch customized skincare products, with the first batch now available on the market.
In 2024, Zhongletang Pharmaceutical established a strategic partnership with a renowned North American pharmacy chain to co‑develop a customized, natural skin‑repair skincare product. Leveraging GMP‑compliant manufacturing, FDA certification, and end‑to‑end delivery capabilities, the project was brought to market in just 45 days—from sampling to launch. The product is now available through the target pharmacy network and has received an enthusiastic response. Looking ahead, it is expected to expand to additional retail locations and online platforms.
Zhongletang Pharmaceutical has created a “full‑scenario solution” for topical dermatological products by manufacturing multi‑dose matrix formulations on a large scale.
Driven by the trend toward product diversification, Zhongletang Pharmaceutical has developed a product portfolio encompassing eight dosage forms—ointments, creams, gels, patches, sprays, and liquid formulations—fully addressing applications such as scar repair, daily skincare, and medical support. Leveraging a 70,000-square-meter smart manufacturing facility and a dedicated R&D and design team, the company delivers flexible customization and scalable production, providing global customers with more comprehensive and professional OEM/ODM solutions.